Ivermectin as an antiparasitic agent for use in humans.

W. Campbell
DOI: https://doi.org/10.1146/ANNUREV.MI.45.100191.002305
IF: 16.232
Annual Review of Microbiology
Abstract:INTRODUCTION.. . . . . . . ........ . . .. . . . .. . . ..... . ...... . . . . .. . . . . .... . . .. . .... 446 INTESTINAL NEMATODES . . ........ . . . . .. . . . . .. . . . . . .. . . . . . . . . . . . . . .. . ......... . .. .. . . ....... . . 446 A scaris lumbricoides ..... . . . . .... ... . . . .. . . . . .. ..... 446 Ho.okwo.rm� (�ncylostoma, Necator). ..... . . .... . . .. . . . . . . . . . . . . . . ..... . . . . . . . . 446 Tnchuns tnchlUra . .. . . . . . . . ..... ..... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 447 Enterobius vermicularis. ..... . . . ..... . . ......... . . .. . . . . . . . . . . . . . .. . . .... . ... . . ....... 448 Strongyloides stercoralis....... . . . . . . . . . . .. . . . . . . .. . . .... . . . . . . . . . . . ........ . . . . . 448 Broad-Spectrum Potential 449 ONCHOCERCIASIS. . . . . . . . . . . . . . . . . . . . . . . . ...... . . . . . . . .. 449 Early Hospital-Based Probes (Phase J) ..... . ..... .. ... . . . .... . . .. . . . . . .... . ... . .. .. 450 Hospital-Based Trials with Reference Treatment (Phase 1/) ... . . . . . . . . .. . 451 Large-Scale Hospital-Based Trials (Phase III) 453 Large-Scale Community-Based Trials (Phase IV) . . . . .. . . . . . . . . . .... ...... .... . . . . ....... . . 454 Effect on the Parasite 455 Effect on Transmission 459 Causal Prophylaxis 461 OTHER FILARIAL INFECTIONS . . . . . . .. . .... . . . .. . . .... . . . .... . . . . . . . . .. . . . . .... . . ... 461 Wuchereria bancrofti ... . .. . .... ....... . ........ . . . . . . .. . . . . . . . . . . ... . . 461 Brugia, Mansonella, Loa.... . . . . . . . . . . .. .. . . .... . . . 464 EFFICACY AGAINST OTHER PARASITES . ... . ... . ... . . . . .. . . . . . . . . . . ......... . . . . . . ....... 464 SAFETY IN HUMANS . . . . . . . . . . . . . . . . ..... .. ... . . . . . . . . . . . .. 465 Safety and Tolerability in Onchocerciasis 465 Safety in Other Infections. . .. .. .... . . . . .... . . . . . . . . ..... . . . . . .... 467 Safety in General 467 CURRENT DRUG DISTRIBUTION..... . . . .. . . . . . . . . . . . .. . . . . . . ..... .... . . . ...... . . . 468
What problem does this paper attempt to address?